Back

Low rate of worsening renal function after 2 years of treatment with edoxaban in patients from the ETNA-AF-Europe study

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Renal Failure and Cardiovascular Disease ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Marianne Gwechenberger

Medical University of Vienna, Vienna (Austria)

187 More presentations in this session

Presentation thumbnail
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
Professor J. McMurray (Glasgow, GB)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation
Doctor C. Su (Taichung, TW)
Abstract Slides
Presentation thumbnail
Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study
Doctor T. Rhee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry
Professor W. Shimizu (Matsudo, JP)
Abstract Slides
Presentation thumbnail
The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.
Doctor S. Alampoondi Venkataramanan (Worcester, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET